← Open Payments lookup

HUBERT DOLUBIZNO: Open Payments

NPI 1578188462 · ALEXANDRIA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$412 in 18 payments from 9 companies in 2025. Trend: 2023 $217 · 2024 $1,730 · 2025 $412

Food & beverage: $412
CompanyPaymentsAmount
Axsome Therapeutics, Inc.1$115
ABBVIE INC.6$102
AstraZeneca Pharmaceuticals LP3$58
Novo Nordisk Inc2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
PFIZER INC.1$19
Exact Sciences Corporation1$15
Takeda Pharmaceuticals U.S.A., Inc.1$15
Boehringer Ingelheim Pharmaceuticals, Inc.1$15

Products named: Auvelity, VRAYLAR, CAPLYTA, UBRELVY, QULIPTA, AIRSUPRA, Ozempic, Wegovy.

Industry payments across IN — which companies pay providers there.